Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2019 Oct 11

PMID 31597448

Citations 5

Authors

Annabelle Rodriguez

Bernardo L Trigatti

Chieko Mineo

Darcy Knaack

John T Wilkins

Daisy Sahoo

Bela F Asztalos

Samia Mora

Marina Cuchel

Henry J Pownall

Corina Rosales

Pascal Bernatchez

Amanda Ribeiro Martins da Silva

Godfrey S Getz

Jacob L Barber

Gregory C Shearer

Angela M Zivkovic

Uwe J F Tietge

Frank M Sacks

Margery A Connelly

Michael N Oda

W Sean Davidson

Mary G Sorci-Thomas

Tomas Vaisar

Giacomo Ruotolo

Kasey C Vickers

Catherine Martel

Affiliations

Soon will be listed here.

Abstract

The HDL (high-density lipoprotein) Workshop was established in 2009 as a forum for candid discussions among academic basic scientists, clinical investigators, and industry researchers about the role of HDL in cardiovascular disease. This ninth HDL Workshop was held on May 16 to 17, 2019 in Boston, MA, and included outstanding oral presentations from established and emerging investigators. The Workshop featured 5 sessions with topics that tackled the role of HDL in the vasculature, its structural complexity, its role in health and disease states, and its interaction with the intestinal microbiome. The highlight of the program was awarding the Jack Oram Award to the distinguished professor emeritus G.S. Getz from the University of Chicago. The tenth HDL Workshop will be held on May 2020 in Chicago and will continue the focus on intellectually stimulating presentations by established and emerging investigators on novel roles of HDL in cardiovascular and noncardiovascular health and disease states.

Citing Articles

HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2.

Trites M, Stebbings B, Aoki H, Phanse S, Akl M, Li L Front Physiol. 2023; 14:1212785.

PMID: 37501930 PMC: 10369849. DOI: 10.3389/fphys.2023.1212785.

A Nutrigenetic Update on CETP Gene-Diet Interactions on Lipid-Related Outcomes.

Wuni R, Kuhnle G, Wynn-Jones A, Vimaleswaran K Curr Atheroscler Rep. 2022; 24(2):119-132.

PMID: 35098451 PMC: 8924099. DOI: 10.1007/s11883-022-00987-y.

Familial Hypercholesterolemia: Do HDL Play a Role?.

Pedro-Botet J, Climent E, Benaiges D Biomedicines. 2021; 9(7).

PMID: 34356876 PMC: 8301335. DOI: 10.3390/biomedicines9070810.

Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.

Murphy K, Harsch B, Healy C, Joshi S, Huang S, Walker R Cardiovasc Res. 2021; 118(4):1061-1073.

PMID: 33752243 PMC: 8930069. DOI: 10.1093/cvr/cvab111.

Coagulatory Defects in Type-1 and Type-2 Diabetes.

Sobczak A, Stewart A Int J Mol Sci. 2020; 20(24).

PMID: 31888259 PMC: 6940903. DOI: 10.3390/ijms20246345.

References

Khera A, Demler O, Adelman S, Collins H, Glynn R, Ridker P . Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation. 2017; 135(25):2494-2504. PMC: 5490983. DOI: 10.1161/CIRCULATIONAHA.116.025678. View

de Boer J, Schonewille M, Dikkers A, Koehorst M, Havinga R, Kuipers F . Transintestinal and Biliary Cholesterol Secretion Both Contribute to Macrophage Reverse Cholesterol Transport in Rats-Brief Report. Arterioscler Thromb Vasc Biol. 2017; 37(4):643-646. DOI: 10.1161/ATVBAHA.116.308558. View

Durham K, Kluck G, Mak K, Deng Y, Trigatti B . Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner. Am J Physiol Heart Circ Physiol. 2019; 316(6):H1447-H1457. DOI: 10.1152/ajpheart.00432.2018. View

Grundy S, Stone N, Bailey A, Beam C, Birtcher K, Blumenthal R . 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018; 139(25):e1082-e1143. PMC: 7403606. DOI: 10.1161/CIR.0000000000000625. View

Xu B, Gillard B, Gotto Jr A, Rosales C, Pownall H . ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate. Arterioscler Thromb Vasc Biol. 2017; 37(12):2260-2270. PMC: 5831354. DOI: 10.1161/ATVBAHA.117.310290. View

Dikkers A, de Boer J, Groen A, Tietge U . Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT. Atherosclerosis. 2015; 243(2):402-6. DOI: 10.1016/j.atherosclerosis.2015.10.010. View

Madsen C, Varbo A, Nordestgaard B . Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017; 38(32):2478-2486. DOI: 10.1093/eurheartj/ehx163. View

Milad N, White Z, Tehrani A, Sellers S, Rossi F, Bernatchez P . Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Skelet Muscle. 2017; 7(1):19. PMC: 5596936. DOI: 10.1186/s13395-017-0135-9. View

Schwartz G, Olsson A, Abt M, Ballantyne C, Barter P, Brumm J . Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012; 367(22):2089-99. DOI: 10.1056/NEJMoa1206797. View

10.

Khera A, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke M, Jafri K . Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364(2):127-35. PMC: 3030449. DOI: 10.1056/NEJMoa1001689. View

11.

Barter P, Caulfield M, Eriksson M, Grundy S, Kastelein J, Komajda M . Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007; 357(21):2109-22. DOI: 10.1056/NEJMoa0706628. View

12.

Mineo C, Shaul P . Regulation of signal transduction by HDL. J Lipid Res. 2013; 54(9):2315-24. PMC: 3735931. DOI: 10.1194/jlr.R039479. View

13.

Milasan A, Tessandier N, Tan S, Brisson A, Boilard E, Martel C . Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis. J Extracell Vesicles. 2016; 5:31427. PMC: 5035515. DOI: 10.3402/jev.v5.31427. View

14.

Shearer G, Borkowski K, Puumala S, Harris W, Pedersen T, Newman J . Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2018; 128:1-10. DOI: 10.1016/j.plefa.2017.10.006. View

15.

Nijstad N, Gautier T, Briand F, Rader D, Tietge U . Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology. 2010; 140(3):1043-51. DOI: 10.1053/j.gastro.2010.11.055. View

16.

Dos Santos Seckler H, Fornelli L, Mutharasan R, Thaxton C, Fellers R, Daviglus M . A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity. J Proteome Res. 2018; 17(6):2156-2164. PMC: 6162093. DOI: 10.1021/acs.jproteome.8b00100. View

17.

Boden W, Probstfield J, Anderson T, Chaitman B, Desvignes-Nickens P, Koprowicz K . Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011; 365(24):2255-67. DOI: 10.1056/NEJMoa1107579. View

18.

Golden D, Kolmakova A, Sura S, Vella A, Manichaikul A, Wang X . Lymphocyte activation gene 3 and coronary artery disease. JCI Insight. 2016; 1(17):e88628. PMC: 5070966. DOI: 10.1172/jci.insight.88628. View

19.

PrabhuDas M, Baldwin C, Bollyky P, Bowdish D, Drickamer K, Febbraio M . A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease. J Immunol. 2017; 198(10):3775-3789. PMC: 5671342. DOI: 10.4049/jimmunol.1700373. View

20.

Rohatgi A, Khera A, Berry J, Givens E, Ayers C, Wedin K . HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014; 371(25):2383-93. PMC: 4308988. DOI: 10.1056/NEJMoa1409065. View